{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:32:36Z","timestamp":1789061556385,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T00:00:00Z","timestamp":1703635200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Zika virus infection causes multiple clinical issues, including Guillain\u2013Barr\u00e9 syndrome and neonatal malformation. Vaccination is considered as the only strategy for the prevention of ZIKV-induced clinical issues. This study developed a plant-based recombinant vaccine that transiently expressed the ZIKV envelope protein (ZikaEnv:aghFc) in <jats:italic>Nicotiana benthamiana<\/jats:italic> and evaluated the protective immunity afforded by it in immunocompetent mice. ZikaEnv:aghFc induced both humoral and cellular immunity at a low dose (1\u20135\u00a0\u03bcg). This immune-inducing potential was enhanced further when adjuvanted CIA09A. In addition, antigen-specific antibodies and neutralizing antibodies were vertically transferred from immunized females to their progeny and afforded both protective immunity to ZIKV and cross-protection to Dengue virus infection. These results suggest that our plant-based ZIKV vaccine provides a safe and efficient protective strategy with a competitive edge.<\/jats:p>","DOI":"10.1038\/s41598-023-47428-7","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T11:02:21Z","timestamp":1703674941000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plant-expressed Zika virus envelope protein elicited protective immunity against the Zika virus in immunocompetent mice"],"prefix":"10.1038","volume":"13","author":[{"given":"Minna","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyangju","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong ryeol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungmin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyou-Nam","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Ju","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Sung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang Je","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Wook","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,27]]},"reference":[{"issue":"5","key":"47428_CR1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","volume":"46","author":"GW Dick","year":"1952","unstructured":"Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus (I). Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46(5), 509\u2013520 (1952).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"9","key":"47428_CR2","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3201\/eid1509.090442","volume":"15","author":"EB Hayes","year":"2009","unstructured":"Hayes, E. B. Zika virus outside Africa. Emerg. Infect. Dis. 15(9), 1347 (2009).","journal-title":"Emerg. Infect. Dis."},{"issue":"10","key":"47428_CR3","doi-asserted-by":"publisher","first-page":"4864","DOI":"10.1128\/JVI.00252-16","volume":"90","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. & Diamond, M. S. Zika virus: new clinical syndromes and its emergence in the Western Hemisphere. J. Virol. 90(10), 4864\u20134875 (2016).","journal-title":"J. Virol."},{"issue":"6300","key":"47428_CR4","doi-asserted-by":"publisher","first-page":"aaf8160","DOI":"10.1126\/science.aaf8160","volume":"353","author":"J Lessler","year":"2016","unstructured":"Lessler, J. et al. Assessing the global threat from Zika virus. Science 353(6300), aaf8160 (2016).","journal-title":"Science"},{"key":"47428_CR5","doi-asserted-by":"crossref","unstructured":"Li, K., Ji, Q., Jiang, S., Zhang, N. Advancement in the Development of Therapeutics Against Zika Virus Infection. Front. Cell. Infect. Microbiol. 938 (2022).","DOI":"10.3389\/fcimb.2022.946957"},{"issue":"6346","key":"47428_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.aam9243","volume":"357","author":"PL Chavali","year":"2017","unstructured":"Chavali, P. L. et al. Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science. 357(6346), 83\u201388 (2017).","journal-title":"Science."},{"issue":"1","key":"47428_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biotechadv.2017.09.004","volume":"36","author":"H-H Lin","year":"2018","unstructured":"Lin, H.-H., Yip, B.-S., Huang, L.-M. & Wu, S.-C. Zika virus structural biology and progress in vaccine development. Biotechnol. Adv. 36(1), 47\u201353 (2018).","journal-title":"Biotechnol. Adv."},{"issue":"9","key":"47428_CR8","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/vaccines9091004","volume":"9","author":"K Zhou","year":"2021","unstructured":"Zhou, K. et al. Current progress in the development of Zika virus vaccines. Vaccines. 9(9), 1004 (2021).","journal-title":"Vaccines."},{"issue":"7720","key":"47428_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","volume":"560","author":"TC Pierson","year":"2018","unstructured":"Pierson, T. C. & Diamond, M. S. The emergence of Zika virus and its new clinical syndromes. Nature. 560(7720), 573\u2013581 (2018).","journal-title":"Nature."},{"issue":"4","key":"47428_CR10","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell. 166(4), 1016\u20131027 (2016).","journal-title":"Cell."},{"issue":"4","key":"47428_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/vaccines7040161","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Effects of adjuvants on the immunogenicity and efficacy of a Zika Virus envelope domain III subunit vaccine. Vaccines. 7(4), 161 (2019).","journal-title":"Vaccines."},{"issue":"11","key":"47428_CR12","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1080\/14760584.2021.1945447","volume":"20","author":"V Cimica","year":"2021","unstructured":"Cimica, V., Galarza, J. M., Rashid, S. & Stedman, T. T. Current development of Zika virus vaccines with special emphasis on virus-like particle technology. Exp. Rev. Vacc. 20(11), 1483\u20131498 (2021).","journal-title":"Exp. Rev. Vacc."},{"issue":"1","key":"47428_CR13","doi-asserted-by":"publisher","first-page":"e00576","DOI":"10.1128\/mSphere.00576-17","volume":"3","author":"A To","year":"2018","unstructured":"To, A. et al. Recombinant Zika virus subunits are immunogenic and efficacious in mice. MSphere. 3(1), e00576-e617 (2018).","journal-title":"MSphere."},{"key":"47428_CR14","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.3389\/fimmu.2018.02464","volume":"9","author":"LO Medina","year":"2018","unstructured":"Medina, L. O. et al. A recombinant subunit based Zika virus vaccine is efficacious in non-human primates. Front. Immunol. 9, 2464 (2018).","journal-title":"Front. Immunol."},{"issue":"1","key":"47428_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-99269-x","volume":"12","author":"M Shin","year":"2022","unstructured":"Shin, M. et al. Zika virus baculovirus-expressed envelope protein elicited humoral and cellular immunity in immunocompetent mice. Sci. Rep. 12(1), 1\u201312 (2022).","journal-title":"Sci. Rep."},{"issue":"2","key":"47428_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/pbi.12796","volume":"16","author":"M Yang","year":"2018","unstructured":"Yang, M., Sun, H., Lai, H., Hurtado, J. & Chen, Q. Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice. Plant Biotechnol. J. 16(2), 572\u2013580 (2018).","journal-title":"Plant Biotechnol. J."},{"issue":"6305","key":"47428_CR17","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1126\/science.aaf6638","volume":"353","author":"GP Lomonossoff","year":"2016","unstructured":"Lomonossoff, G. P. & D\u2019Aoust, M.-A. Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment. Science. 353(6305), 1237\u20131240 (2016).","journal-title":"Science."},{"issue":"12","key":"47428_CR18","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1080\/21645515.2017.1356497","volume":"13","author":"EP Rybicki","year":"2017","unstructured":"Rybicki, E. P. Plant-made vaccines and reagents for the One Health initiative. Human Vacc. Immunotherap. 13(12), 2912\u20132917 (2017).","journal-title":"Human Vacc. Immunotherap."},{"issue":"12","key":"47428_CR19","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s10529-014-1621-3","volume":"36","author":"M Sabalza","year":"2014","unstructured":"Sabalza, M., Christou, P. & Capell, T. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks. Biotechnol. Lett. 36(12), 2367\u20132379 (2014).","journal-title":"Biotechnol. Lett."},{"issue":"2","key":"47428_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/pbi.12986","volume":"17","author":"RC Laughlin","year":"2019","unstructured":"Laughlin, R. C. et al. Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever. Plant Biotechnol. J. 17(2), 410\u2013420 (2019).","journal-title":"Plant Biotechnol. J."},{"key":"47428_CR21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3389\/fpls.2019.00624","volume":"10","author":"Y Park","year":"2019","unstructured":"Park, Y. et al. Development of recombinant protein-based vaccine against classical swine fever virus in pigs using transgenic Nicotiana benthamiana. Front. Plant Sci. 10, 624 (2019).","journal-title":"Front. Plant Sci."},{"issue":"10261","key":"47428_CR22","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/S0140-6736(20)32010-9","volume":"396","author":"JS Tregoning","year":"2020","unstructured":"Tregoning, J. S. First human efficacy study of a plant-derived influenza vaccine. The Lancet. 396(10261), 1464\u20131465 (2020).","journal-title":"The Lancet."},{"issue":"10261","key":"47428_CR23","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/S0140-6736(20)32014-6","volume":"396","author":"BJ Ward","year":"2020","unstructured":"Ward, B. J. et al. Efficacy, immunogenicity, and safety of a plant-derived, quadrivalent, virus-like particle influenza vaccine in adults (18\u201364 years) and older adults (\u2265 65 years): Two multicentre, randomised phase 3 trials. The Lancet. 396(10261), 1491\u20131503 (2020).","journal-title":"The Lancet."},{"issue":"5\u20136","key":"47428_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/2051013615613272","volume":"3","author":"N Takeyama","year":"2015","unstructured":"Takeyama, N., Kiyono, H. & Yuki, Y. Plant-based vaccines for animals and humans: recent advances in technology and clinical trials. Therap. Adv. Vacc. 3(5\u20136), 139\u2013154 (2015).","journal-title":"Therap. Adv. Vacc."},{"issue":"22","key":"47428_CR25","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1056\/NEJMoa2201300","volume":"386","author":"KJ Hager","year":"2022","unstructured":"Hager, K. J. et al. Efficacy and safety of a recombinant plant-based adjuvanted Covid-19 vaccine. N. Eng. J. Med. 386(22), 2084\u20132096 (2022).","journal-title":"N. Eng. J. Med."},{"issue":"6","key":"47428_CR26","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1586\/14760584.2014.912134","volume":"13","author":"N Zhang","year":"2014","unstructured":"Zhang, N., Jiang, S. & Du, L. Current advancements and potential strategies in the development of MERS-CoV vaccines. Exp. Rev. Vacc. 13(6), 761\u2013774 (2014).","journal-title":"Exp. Rev. Vacc."},{"issue":"10","key":"47428_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/14760584.2017.1363648","volume":"16","author":"L Du","year":"2017","unstructured":"Du, L., Zhou, Y. & Jiang, S. The latest advancements in Zika virus vaccine development. Exp. Rev. Vacc. 16(10), 951\u2013954 (2017).","journal-title":"Exp. Rev. Vacc."},{"issue":"8","key":"47428_CR28","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/14760584.2017.1345309","volume":"16","author":"A Durbin","year":"2017","unstructured":"Durbin, A. & Wilder-Smith, A. An update on Zika vaccine developments. Exp. Rev. Vacc. 16(8), 781\u2013787 (2017).","journal-title":"Exp. Rev. Vacc."},{"issue":"1","key":"47428_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.imlet.2005.08.002","volume":"102","author":"JM Brewer","year":"2006","unstructured":"Brewer, J. M. (How) do aluminium adjuvants work?. Immunol. Lett. 102(1), 10\u201315 (2006).","journal-title":"Immunol. Lett."},{"issue":"27\u201328","key":"47428_CR30","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","volume":"22","author":"EB Lindblad","year":"2004","unstructured":"Lindblad, E. B. Aluminium adjuvants\u2014in retrospect and prospect. Vaccine. 22(27\u201328), 3658\u20133668 (2004).","journal-title":"Vaccine."},{"issue":"1","key":"47428_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","volume":"30","author":"SG Reed","year":"2009","unstructured":"Reed, S. G., Bertholet, S., Coler, R. N. & Friede, M. New horizons in adjuvants for vaccine development. Trends Immunol. 30(1), 23\u201332 (2009).","journal-title":"Trends Immunol."},{"issue":"2","key":"47428_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","volume":"15","author":"S Lee","year":"2015","unstructured":"Lee, S. & Nguyen, M. T. Recent advances of vaccine adjuvants for infectious diseases. Immune network. 15(2), 51\u201357 (2015).","journal-title":"Immune network."},{"issue":"4","key":"47428_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"RL Coffman","year":"2010","unstructured":"Coffman, R. L., Sher, A. & Seder, R. A. Vaccine adjuvants: putting innate immunity to work. Immunity. 33(4), 492\u2013503 (2010).","journal-title":"Immunity."},{"issue":"5","key":"47428_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0923-2494(92)80058-S","volume":"143","author":"G Gustafson","year":"1992","unstructured":"Gustafson, G. & Rhodes, M. Bacterial cell wall products as adjuvants: early interferon gamma as a marker for adjuvants that enhance protective immunity. Res. Immunol. (Paris). 143(5), 483\u2013488 (1992).","journal-title":"Res. Immunol. (Paris)."},{"issue":"20","key":"47428_CR35","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","volume":"65","author":"CR Casella","year":"2008","unstructured":"Casella, C. R. & Mitchell, T. C. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell. Mol. Life Sci. 65(20), 3231\u20133240 (2008).","journal-title":"Cell. Mol. Life Sci."},{"issue":"9","key":"47428_CR36","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.intimp.2011.03.020","volume":"11","author":"SR Wui","year":"2011","unstructured":"Wui, S. R. et al. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice. Int. Immunopharmacol. 11(9), 1195\u20131204 (2011).","journal-title":"Int. Immunopharmacol."},{"issue":"28","key":"47428_CR37","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1016\/j.vaccine.2012.04.079","volume":"30","author":"JE Han","year":"2012","unstructured":"Han, J. E. et al. Comparison of the immune responses to the CIA06-adjuvanted human papillomavirus L1 VLP vaccine with those against the licensed HPV vaccine Cervarix\u2122 in mice. Vaccine. 30(28), 4127\u20134134 (2012).","journal-title":"Vaccine."},{"key":"47428_CR38","doi-asserted-by":"crossref","unstructured":"Ryu, J. I., Park, S., Wui, S. R., Ko, A., Han, J. E., Choi, J. A., & Lee, N. G. (2016). A de-O-acylated lipooligosaccharide-based adjuvant system promotes antibody and Th1-type immune responses to H1N1 pandemic influenza vaccine in mice. BioMed Res. Int. (2016).","DOI":"10.1155\/2016\/3713656"},{"issue":"8","key":"47428_CR39","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.4014\/jmb.1706.06009","volume":"27","author":"JI Ryu","year":"2017","unstructured":"Ryu, J. I. et al. Increased immunogenicity and protective efficacy of a P aeruginosa vaccine in mice using an alum and de-O-acylated lipooligosaccharide adjuvant system. J. Microbiol. Biotechnol. 27(8), 1539\u20131548 (2017).","journal-title":"J. Microbiol. Biotechnol."},{"issue":"2","key":"47428_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12272-017-0985-z","volume":"41","author":"A Ko","year":"2018","unstructured":"Ko, A. et al. Comparison of the adjuvanticity of two adjuvant formulations containing de-O-acylated lipooligosaccharide on Japanese encephalitis vaccine in mice. Arch. Pharm. Res. 41(2), 219\u2013228 (2018).","journal-title":"Arch. Pharm. Res."},{"issue":"3","key":"47428_CR41","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/pharmaceutics13030390","volume":"13","author":"SR Wui","year":"2021","unstructured":"Wui, S. R. et al. The effect of a TLR4 agonist\/cationic liposome adjuvant on varicella-zoster virus glycoprotein e vaccine efficacy: antigen presentation, uptake, and delivery to lymph nodes. Pharmaceutics. 13(3), 390 (2021).","journal-title":"Pharmaceutics."},{"issue":"15","key":"47428_CR42","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/j.vaccine.2019.02.048","volume":"37","author":"SR Wui","year":"2019","unstructured":"Wui, S. R. et al. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice. Vaccine. 37(15), 2131\u20132141 (2019).","journal-title":"Vaccine."},{"issue":"3","key":"47428_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000452950","volume":"59","author":"MI Faizan","year":"2016","unstructured":"Faizan, M. I. et al. Zika virus-induced microcephaly and its possible molecular mechanism. Intervirology. 59(3), 152\u2013158 (2016).","journal-title":"Intervirology."},{"issue":"2","key":"47428_CR44","doi-asserted-by":"publisher","first-page":"432","DOI":"10.4269\/ajtmh.17-0685","volume":"98","author":"DR Smith","year":"2018","unstructured":"Smith, D. R. et al. African and Asian Zika virus isolates display phenotypic differences both in vitro and in vivo. Am. J. Trop. Med. Hyg. 98(2), 432 (2018).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"9","key":"47428_CR45","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat. Immunol. 17(9), 1102\u20131108 (2016).","journal-title":"Nat. Immunol."},{"key":"47428_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coviro.2017.03.006","volume":"23","author":"E Fernandez","year":"2017","unstructured":"Fernandez, E. & Diamond, M. S. Vaccination strategies against Zika virus. Curr. Op. Virol. 23, 59\u201367 (2017).","journal-title":"Curr. Op. Virol."},{"issue":"20","key":"47428_CR47","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen, S. A., Jamieson, D. J., Honein, M. A. & Petersen, L. R. Zika virus and birth defects\u2014reviewing the evidence for causality. N. Engl. J. Med. 374(20), 1981\u20131987 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"47428_CR48","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1096\/fj.02-0872fje","volume":"17","author":"M Bublin","year":"2003","unstructured":"Bublin, M. et al. Cross-reactive N-glycans of Api g 5, a high molecular weight glycoprotein allergen from celery, are required for immunoglobulin E binding and activation of effector cells from allergic patients. The FASEB J. 17(12), 1697\u20131699 (2003).","journal-title":"The FASEB J."},{"issue":"3","key":"47428_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0091-6749(95)70178-8","volume":"95","author":"R van Ree","year":"1995","unstructured":"van Ree, R., Fern\u00e1ndez-Rivas, M., Cuevas, M., van Wijngaarden, M. & Aalberse, R. C. Pollen-related allergy to peach and apple: an important role for profilin. J. Aller. Clin. Immunol. 95(3), 726\u2013734 (1995).","journal-title":"J. Aller. Clin. Immunol."},{"issue":"6","key":"47428_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1034\/j.1398-9995.2002.23308.x","volume":"57","author":"A Kwaasi","year":"2002","unstructured":"Kwaasi, A. et al. Cross-reactivities between date palm (Phoenix dactylifera L.) polypeptides and foods implicated in the oral allergy syndrome. Allergy. 57(6), 508\u2013518 (2002).","journal-title":"Allergy."},{"issue":"15","key":"47428_CR51","doi-asserted-by":"publisher","first-page":"11451","DOI":"10.1074\/jbc.275.15.11451","volume":"275","author":"R Van Ree","year":"2000","unstructured":"Van Ree, R. et al. \u03b2 (1, 2)-xylose and \u03b1 (1, 3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J. Biol. Chem. 275(15), 11451\u201311458 (2000).","journal-title":"J. Biol. Chem."},{"issue":"46","key":"47428_CR52","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.1016\/j.vaccine.2014.08.079","volume":"32","author":"BJ Ward","year":"2014","unstructured":"Ward, B. J. et al. Human antibody response to N-glycans present on plant-made influenza virus-like particle (VLP) vaccines. Vaccine. 32(46), 6098\u20136106 (2014).","journal-title":"Vaccine."},{"issue":"5","key":"47428_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","volume":"18","author":"H Tang","year":"2016","unstructured":"Tang, H. et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell. 18(5), 587\u2013590 (2016).","journal-title":"Cell Stem Cell."},{"issue":"6","key":"47428_CR54","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.stem.2016.11.014","volume":"19","author":"G-l Ming","year":"2016","unstructured":"Ming, G.-l, Tang, H. & Song, H. Advances in Zika virus research: stem cell models, challenges, and opportunities. Cell Stem Cell. 19(6), 690\u2013702 (2016).","journal-title":"Cell Stem Cell."},{"issue":"6","key":"47428_CR55","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","volume":"5","author":"TC Pierson","year":"2020","unstructured":"Pierson, T. C. & Diamond, M. S. The continued threat of emerging flaviviruses. Nat. Microbiol. 5(6), 796\u2013812 (2020).","journal-title":"Nat. Microbiol."},{"key":"47428_CR56","doi-asserted-by":"crossref","unstructured":"Shin, M., Kim, J., Park, J., Hahn, T.-W. Clinical profile of Asian and African strains of Zika virus in immunocompetent mice. Korean J. Vet. Res. 61(2) (2021).","DOI":"10.14405\/kjvr.2021.61.e12"},{"issue":"1","key":"47428_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-022-00485-6","volume":"50","author":"M Shin","year":"2022","unstructured":"Shin, M. et al. Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice. Trop. Med. Health. 50(1), 1\u201311 (2022).","journal-title":"Trop. Med. Health."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47428-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47428-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T15:02:31Z","timestamp":1703948551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-47428-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,27]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["47428"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-47428-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,27]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HV20C0161).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22955"}}